Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
Tevogen Bio Holdings (NASDAQ: TVGN) has announced plans to provide detailed guidance on the Direct Registration System (DRS) process in response to increased shareholder inquiries. The announcement follows growing interest from shareholders seeking information on transferring their shares to DRS accounts. The company revealed that several of its major shareholders, both internal and external, have already opted for DRS as their preferred method of share ownership, demonstrating confidence in this direct ownership approach.
The company will release step-by-step instructions next week to assist shareholders in registering their shares directly with Continental Stock Transfer & Trust, Tevogen's transfer agent.
Tevogen Bio Holdings (NASDAQ: TVGN) ha annunciato l'intenzione di fornire indicazioni dettagliate sul processo del Direct Registration System (DRS) in risposta al crescente numero di richieste da parte degli azionisti. L'annuncio arriva a seguito dell'interesse crescente degli azionisti che desiderano trasferire le proprie azioni su conti DRS. La società ha rivelato che diversi dei suoi principali azionisti, sia interni che esterni, hanno già scelto il DRS come metodo preferito di proprietà azionaria, dimostrando fiducia in questo approccio diretto.
La società pubblicherà la prossima settimana istruzioni passo-passo per aiutare gli azionisti a registrare direttamente le proprie azioni presso Continental Stock Transfer & Trust, l'agente di trasferimento di Tevogen.
Tevogen Bio Holdings (NASDAQ: TVGN) ha anunciado planes para ofrecer una guía detallada sobre el proceso del Direct Registration System (DRS) en respuesta al aumento de consultas de los accionistas. El anuncio sigue al creciente interés de los accionistas que buscan información sobre cómo transferir sus acciones a cuentas DRS. La compañía reveló que varios de sus principales accionistas, tanto internos como externos, ya han optado por el DRS como su método preferido de propiedad de acciones, demostrando confianza en este enfoque de propiedad directa.
La empresa publicará la próxima semana instrucciones paso a paso para ayudar a los accionistas a registrar sus acciones directamente con Continental Stock Transfer & Trust, el agente de transferencia de Tevogen.
Tevogen Bio Holdings (NASDAQ: TVGN)은 주주들의 문의가 증가함에 따라 Direct Registration System (DRS) 절차에 대한 상세한 안내를 제공할 계획이라고 발표했습니다. 이번 발표는 주식 보유를 DRS 계좌로 이전하는 방법에 대한 주주들의 관심이 커진 데 따른 것입니다. 회사는 내부 및 외부의 주요 주주 여러 명이 이미 DRS를 선호하는 주식 소유 방식으로 선택해 이 직접 소유 방식에 대한 신뢰를 보여주고 있다고 밝혔습니다.
회사는 다음 주에 주주들이 Tevogen의 주식 이전 대리인인 Continental Stock Transfer & Trust에 직접 주식을 등록할 수 있도록 단계별 지침을 제공할 예정입니다.
Tevogen Bio Holdings (NASDAQ : TVGN) a annoncé son intention de fournir des instructions détaillées sur le processus du Direct Registration System (DRS) en réponse à une augmentation des demandes des actionnaires. Cette annonce fait suite à l'intérêt croissant des actionnaires souhaitant transférer leurs actions vers des comptes DRS. La société a révélé que plusieurs de ses principaux actionnaires, internes et externes, ont déjà choisi le DRS comme méthode privilégiée de détention d'actions, témoignant de leur confiance dans cette approche de propriété directe.
La société publiera la semaine prochaine des instructions étape par étape pour aider les actionnaires à enregistrer directement leurs actions auprès de Continental Stock Transfer & Trust, l'agent de transfert de Tevogen.
Tevogen Bio Holdings (NASDAQ: TVGN) hat Pläne angekündigt, detaillierte Anleitungen zum Direct Registration System (DRS)-Verfahren bereitzustellen, als Reaktion auf vermehrte Anfragen von Aktionären. Die Ankündigung folgt einem wachsenden Interesse von Aktionären, die Informationen zur Übertragung ihrer Aktien auf DRS-Konten suchen. Das Unternehmen gab bekannt, dass mehrere seiner Hauptaktionäre, sowohl intern als auch extern, bereits DRS als bevorzugte Form des Aktienbesitzes gewählt haben, was Vertrauen in diesen direkten Eigentumsansatz zeigt.
Das Unternehmen wird nächste Woche Schritt-für-Schritt-Anleitungen veröffentlichen, um Aktionären bei der direkten Registrierung ihrer Aktien bei Continental Stock Transfer & Trust, dem Transferagenten von Tevogen, zu helfen.
- None.
- None.
WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that, following the Company’s recent press release highlighting the Direct Registration System (DRS) as a secure method of share ownership, it has received a number of inquiries from shareholders seeking additional information on how to transfer their shares to a DRS account.
In response, Tevogen will provide step-by-step guidance early next week to help interested shareholders register their shares directly with the Company’s transfer agent, Continental Stock Transfer & Trust.
The Company also notes that several of its largest shareholders, both internal and external, have elected to hold their shares via DRS, underscoring their confidence in this method of direct ownership.
Contacts
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
Communications@Tevogen.com
FAQ
What is the Direct Registration System (DRS) that Tevogen Bio (TVGN) is promoting?
When will Tevogen (TVGN) release the DRS transfer instructions for shareholders?
Who is Tevogen's transfer agent for DRS registration?
Have any major Tevogen (TVGN) shareholders adopted the DRS method?
